Ishita Drugs & Industries Limited is the flagship company of ISHITA group. It is engaged in manufacture of various Active Pharma Ingredients, drug intermediates, fine chemicals and excipients.Product Portfolio: a) Active Pharma Ingredients: Sulfa Drugs / Sulfonamides, Vitamins, Fluoro Quinolones, Antibiotics, Anthelmintics, Iodides & Citrates (Salts), Food Additives / Excipients,...
Ishita Drugs & Industries announced its 33rd Annual General Meeting will convene on September 30, 2026, at 11:30 AM in Gujarat. To ensure all investors have access, the company has dispatched letters to shareholders without registered email addresses. These letters provide a web-link to the AGM Notice and the Annual...
Annual Report for the Financial Year 2025-26 including Notice of 33rd Annual General Meeting of the Company to be held on 30.09.2026.
Notice of 33RD AGM of the Company which will be held on wednesday, 30th September, 2026 and E voting period for AGM commence from 27.09.2026 (09:00 a.m. IST) and ends on 29.09.2026 (5:00 p.m. IST)
The E-voting period for ensuing 33rd AGM which is to be held on 30.09.2026 will commence from 27.09.2026 (09:00 a.m. IST) and ends on 29.09.2026 (05:00 p.m. IST) (Both days inclusive).
Ishita Drugs & Industries Ltd. has announced its 33rd Annual General Meeting (AGM) will be held on 30th September, 2026, at 11:30 a.m. in Gujarat. For the purpose of the AGM, the company's Register of Members and Share Transfer Book will remain closed from 24th September, 2026, to 30th September,...
